Kenneth Boyer to Pyrimethamine
This is a "connection" page, showing publications Kenneth Boyer has written about Pyrimethamine.
Connection Strength
0.191
-
Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics. 1995 Jan; 95(1):11-20.
Score: 0.033
-
Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group. Antimicrob Agents Chemother. 1992 May; 36(5):1040-8.
Score: 0.027
-
Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy. Arch Ophthalmol. 2008 Aug; 126(8):1152-6.
Score: 0.021
-
Cataracts in congenital toxoplasmosis. J AAPOS. 2007 Dec; 11(6):551-4.
Score: 0.020
-
Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Ophthalmology. 2008 Mar; 115(3):553-559.e8.
Score: 0.020
-
Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis. 2006 May 15; 42(10):1383-94.
Score: 0.018
-
Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis. Pediatr Infect Dis J. 2006 Mar; 25(3):270-2.
Score: 0.018
-
The child with congenital toxoplasmosis. Curr Clin Top Infect Dis. 2000; 20:189-208.
Score: 0.012
-
Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis. Radiology. 1996 May; 199(2):433-40.
Score: 0.009
-
Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis. 1994 Jan; 18(1):38-72.
Score: 0.008
-
Phenotypes and functions of lymphocytes in congenital toxoplasmosis. J Lab Clin Med. 1990 Nov; 116(5):623-35.
Score: 0.006